Skip to main content
medichelpline
Join Free
Back to Drug Index
General MedicationsORALGeneric

EXTENDED PHENYTOIN SODIUM

PHENYTOIN SODIUM

Standard Dose
200MG EXTENDED
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued

Key Takeaways

  • Primary indication: Review priority: STANDARD Marketing status: Discontinued
  • Approval overview EXTENDED PHENYTOIN SODIUM is listed in Drugs@FDA under application 040731 (ANDA).
  • Review priority: STANDARD Marketing status: Discontinued Active ingredient PHENYTOIN SODIUM Form and strength CAPSULE;ORAL - 200MG EXTENDED Sponsor SUN PHARM INDS Submission history Latest submission status date: 2023-03-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview EXTENDED PHENYTOIN SODIUM is listed in Drugs@FDA under application 040731 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient PHENYTOIN SODIUM Form and strength CAPSULE;ORAL - 200MG EXTENDED Sponsor SUN PHARM INDS Submission history Latest submission status date: 2023-03-28 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.